|
|
Content :
Our Publications
Shareholder publications
- Letter to Shareholders - June 2008 (new window, PDF, 0.9 MB)
- Letter to Shareholders - March 2008 (new window, PDF, 0.3 MB)
- Letter to Shareholders - December 2007 (new window, PDF, 0.5 MB)
- Letter to Shareholders - September 2007 (new window, PDF, 0.5 MB)
- Letter to Shareholders - June/July 2007 (new window, PDF, 0.7 MB)
- Letter to Shareholders - March 2007 (new window, PDF, 0.5 MB)
- More Letters to Shareholders
- Individual shareholder handbook - 2007-2008 edition (new window, PDF, 1.5 MB)
- Further information about the Individual shareholder handbook
- Order some of our shareholder publications
Financial publications
- Annual review 2007 (new window, PDF, 3 MB)
- Sustainability report 2007 (new window, PDF, 2.7 MB)
- Annual report on form 20-F 2007 (new window, PDF, 1.1 MB)
- Document de référence 2007 (in French) (new window, PDF, 5.8 MB)
- Half-year financial report 2007 (new window, PDF, 0.5 MB)
- Business report 2006 (new window, PDF, 3.4 MB)
- Sustainable development report 2006 (new window, PDF, 12.4 MB)
- Reference Document 2006 (in French) (new window, PDF, 4.1 MB)
- Annual report on form 20-F 2006 (new window, PDF, 2.7 MB)
- Management report for the first half of 2006 (new window, PDF, 0.5 MB)
- Interim consolidated financial statements - June 30, 2006 (new window, PDF, 0.4 MB)
- Business Report 2005 (new window, PDF, 4.3 MB)
- Sustainable Development Report 2005 (new window, PDF, 2.1 MB)
- Reference document 2005 (in French) (new window, PDF, 1.6 MB)
- Reference document 2005 (German version) (new window, PDF, 1.4 MB)
- Form 20-F 2005 (new window, PDF, 1.1 MB)
- Download our financial reports since 2000
- Order some of our financial publications
Financial notices
- Financial notice published in the Wall Street Journal Europe issue of May 6, 2008: Encouraging first-quarter 2008 results - Further positive Phase III results for eplivanserin (new window, PDF, 0.1 MB)
- Financial notice published in the Financial Times issue of May 5, 2008: Encouraging first-quarter 2008 results - Further positive Phase III results for eplivanserin (new window, PDF, 0.1 MB)
- Anzeige im Handelsblatt vom 6. Mai 2008: Ermutigendes Ergebnis im ersten Quartal 2008 - Erneut positives Ergebnis in der Phase-III-Studie für Eplivanserin (new window, PDF, 0.1 MB)
- Financial notice published in the Financial Times issue of February 14, 2008: 2007 earnings ahead of guidance - Sharp rise in proposed dividend (new window, PDF, 0.1 MB)
- Anzeige im Handelsblatt vom 14. Februar 2008: Ergebnis 2007 übersteigt die Prognose - Deutliche Erhöhung des Dividendenvorschlags (new window, PDF, 0.3 MB)
Miscellanous
|
Slots :
Stock information
Quote: €46.38
. Level change: +0.49%
Last update: July 24, 2008
05.39 PM (CET)
Quote: $36.29
. Level change: +0.58%
Last update: July 24, 2008
04.13 PM (EST)
|
